Skip to main content
Livermore
Livermore
ZHEN

Replimune Group, Inc.

REPL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001737953

In the last 90 days, Replimune Group, Inc. insiders filed 0 open-market purchases and 5 sales; 199 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding Replimune Group, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of REPL: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders1491144−4
Shares70.9M4.71M69.9M+3.76M (+5.7%)
Value$638.1M$42.4M$766.7M+$171.0M (+28.7%)

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (23)

Institutions that held Replimune Group, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to REPL in Q3 2024
InstitutionSharesValue% of portfolio
BlackRock, Inc.5,471,564$60.0M0.00%
ExodusPoint Capital Management, LP422,914$4.63M0.05%
Rafferty Asset Management, LLC101,214$1.11M0.00%
Arizona PSPRS Trust76,100$834.1K0.03%
Sofinnova Investments, Inc.48,138$527.6K0.04%
AQR Capital Management LLC27,786$304.5K0.00%
Bayesian Capital Management, LP23,975$262.8K0.03%
Intech Investment Management LLC23,003$252.1K0.00%
SG Americas Securities, LLC22,917$251.0K0.00%
Profund Advisors LLC20,416$223.8K0.01%
Gsa Capital Partners LLP20,254$222.0K0.02%
Squarepoint Ops LLC19,564$214.4K0.00%
Bank of Montreal13,889$155.0K0.00%
Federated Hermes, Inc.5,136$56.3K0.00%
Group One Trading, L.P.4,339$47.6K0.00%
Public Employees Retirement Association of Colorado2,712$30.0K0.00%
nVerses Capital, LLC1,300$14.2K0.01%
Sterling Capital Management LLC454$4.98K0.00%
Versant Capital Management, Inc123$1.35K0.00%
Aster Capital Management (DIFC) Ltd93$1.02K0.00%
Bessemer Group Inc120$1.00K0.00%
Capital Performance Advisors LLP76$8330.00%
True Wealth Design, LLC59$6470.00%

Sold out (27)

Institutions that held Replimune Group, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of REPL in Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
Atlas Venture Life Science Advisors, LLC2,098,300$18.9M
Camber Capital Management LP1,350,000$12.2M
Jefferies Financial Group Inc.1,000,000$9.00M
Acadian Asset Management LLC185,516$1.67M
HRT Financial LP184,761$1.66M
Cantor Fitzgerald, L. P.145,919$1.31M
Cubist Systematic Strategies, LLC72,207$649.9K
Campbell & CO Investment Adviser LLC70,113$631.0K
Atom Investors LP66,071$594.6K
Panagora Asset Management Inc57,043$513.4K
Y-Intercept (Hong Kong) Ltd52,112$469.0K
Walleye Capital LLC49,754$447.8K
Point72 Asia (Singapore) Pte. Ltd.49,261$443.4K
Prudential Financial Inc42,820$385.4K
Brevan Howard Capital Management LP39,170$352.5K
Pennant Investors, LP30,500$274.5K
Alyeska Investment Group, L.P.29,460$265.1K
Deerfield Management Company, L.P. (Series C)29,300$263.7K
HSBC Holdings PLC29,344$252.9K
Laurion Capital Management LP19,707$177.4K
Ameriprise Financial Inc18,555$167.0K
XTX Topco Ltd14,505$130.5K
Arizona State Retirement System12,029$108.3K
Diversified Trust Co11,638$104.7K
Centiva Capital, LP11,134$100.2K
EntryPoint Capital, LLC8,051$72.5K
Point72 (DIFC) Ltd6,325$56.9K

Not filed for Q3 2024 yet (1)

Institutions that held Replimune Group, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding REPL in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
BlackRock Inc.4,713,791$42.4M